William M. Gallagher

24.8k citations

257 papers · 15.6k indexed · 5 hit papers · h-index 61

Impact in

Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers

Papers in

Cancer Research 60
- Cancer Genomics and Diagnostics 18
Oncology 80
- Cancer-related Molecular Pathways 19
- HER2/EGFR in Cancer Research 18

Co-authors: Annette T. Byrne Aisling O’Connor Donal J. Brennan Donal F. O’Shea Darran P. O’Connor Elton Rexhepaj J. Killoran Karin Jirström
Journals: Cancer Research (23 papers)Journal of Clinical Oncology (11 papers)Expert Review of Molecular Diagnostics (7 papers)BMC Cancer (6 papers)Oncogene (6 papers)
Partner nations: Ireland United States Sweden

In The Last Decade

William M. Gallagher

250 papers receiving 15.4k citations

Hit Papers

5 papers align trajectories log scale

Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses 2012 · 759 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 Cancer Research
2011 Cancer Discovery
2009 Photochemistry and Photobiology
2008 Proceedings of the National Academy of Sciences
2004 Journal of the American Chemical Society

Peers

Countries citing papers authored by William M. Gallagher

Since Specialization

Citations

This map shows the geographic impact of William M. Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William M. Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William M. Gallagher more than expected).

Fields of papers citing papers by William M. Gallagher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William M. Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William M. Gallagher. The network helps show where William M. Gallagher may publish in the future.

Co-authors

The 25 scholars most cited alongside William M. Gallagher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William M. Gallagher Line = papers co-authored together William M. Gallagher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prediction of post-treatment recurrence in early-stage breast cancer using deep-learning with mid-infrared chemical histopathological imaging npj Precision Oncology ·Abigail Keogan, Thi Nguyet Que Nguyen, Pascaline Bouzy, Nicholas Stone, Karin Jirström, Arman Rahman, William M. Gallagher, Aidan D. Meade	2025	2
2	A clinically relevant computed tomography (CT) radiomics strategy for intracranial rodent brain tumour monitoring Scientific Reports ·Kate Connor, Emer Conroy, Kieron White, Liam P. Shiels, Simon Keek, Abdalla Ibrahim, William M. Gallagher, Kieron J. Sweeney, James Clerkin, David O’Brien, Jane Cryan, Philip J. O’Halloran, Josephine Heffernan, Francesca Brett, Philippe Lambin, Henry C. Woodruff, Annette T. Byrne	2024	2
3	Deciphering epigenetic regulation of enhancers in high‐risk prostate cancer Genes Chromosomes and Cancer ·Alexandra V. Tuzova, Bruce Moran, N. M. Russell, Sudipto Das, Fabien Delahaye, R. Silva, Ciara Barrett, R. William G. Watson, Amanda O’Neill, William M. Gallagher, John M. Greally, Antoinette S. Perry	2024	2
4	IMPROVER (Involving Men with Prostate Cancer in Engaged Research): Assessing Patient Experience With Testing, Diagnosis, And Surveillance Clinical Genitourinary Cancer ·M. C. Walsh, Asia Jordan, Lea Schäfer, Jana Joha, Ben Heapes, Megan Noonan, William M. Gallagher, H. W. Gallagher, Rustom P. Manecksha, David Galvin, Greg Nason, Terri R. Martin, C. Lyons, Robert O’Connor, Frances J. Drummond, Claire Kilty, Antoinette S. Perry	2024	1
5	1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model Frontiers in Medicine ·Kayleigh Slater, Rosa Bosch, Kaelin Francis Smith, Chowdhury Arif Jahangir, Sandra García‐Mulero, Arman Rahman, Fiona O’Connell, Josep M. Piulats, Valerie O’Neill, Noel Horgan, Sarah E. Coupland, Jacintha O’Sullivan, William M. Gallagher, Alberto Villanueva, Breandán N. Kennedy	2023	7
6	Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell–Cell Interactions That Predict Immunotherapy Response Cancer Research ·Asier Antoranz, Yannick Van Herck, Maddalena M. Bolognesi, Seodhna M. Lynch, Arman Rahman, William M. Gallagher, Veerle Boecxstaens, Jean‐Christophe Marine, Giorgio Cattoretti, Joost J. van den Oord, Frederik De Smet, Oliver Bechter, Francesca M. Bosisio	2022	22
7	The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor–Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8 Clinical Cancer Research ·Martin Filipits, Margaretha Rudas, Verena Kainz, Christian F. Singer, Florian Fitzal, Zsuzsanna Bagó-Horváth, Richard Greil, Marija Balić, Peter Regitnig, Stefan Halper, Wolfgang Hulla, Daniel Egle, Stephen Barron, Tony Loughman, Des O'Leary, William M. Gallagher, Dominik Hlauschek, Michael Gnant, Peter Dubsky	2021	1
8	Advances in tissue-based imaging: impact on oncology research and clinical practice Expert Review of Molecular Diagnostics ·Arman Rahman, Chowdhury Arif Jahangir, Seodhna M. Lynch, Nebras Al-Attar, Claudia Aura, Niamh Russell, Fiona Lanigan, William M. Gallagher	2020	10
9	Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer QUT ePrints (Queensland University of Technology) ·Dermot S. O’Callaghan, Elton Rexhepaj, Kathy Gately, Linda Coate, David Delaney, Dearbhaile M. O’Donnell, Elaine W. Kay, Finbarr O’Connell, William M. Gallagher, Kenneth J. O’Byrne	2015	3
10	Proteomic Portrait of Human Breast Cancer Progression Identifies Novel Prognostic Markers Cancer Research ·Tamar Geiger, Stephen F. Madden, William M. Gallagher, Jüergen Cox, Matthias Mann	2012	115
11	miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro Clinical Cancer Research ·Laoighse Mulrane, Stephen F. Madden, Donal J. Brennan, Gabriela Gremel, Sharon F. McGee, Sara McNally, Finian Martin, John Crown, Karin Jirström, Desmond G. Higgins, William M. Gallagher, Darran P. O’Connor	2012	71
12	Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses Cancer Research ·Jonathan B. Mitchem, Donal J. Brennan, Brett L. Knolhoff, Brian A. Belt, Yu Zhu, Dominic E. Sanford, Larisa Belaygorod, Danielle Carpenter, Lynne Collins, David Piwnica‐Worms, Stephen M. Hewitt, Girish Mallya Udupi, William M. Gallagher, Craig D. Wegner, Brian L. West, Andrea Wang‐Gillam, Peter S. Goedegebuure, David C. Linehan, David G. DeNardo Hit paper breakdown →	2012	759
13	Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer Clinical Cancer Research ·Jermaine Coward, Hagen Kulbe, Probir Chakravarty, David P. Leader, Vessela Vassileva, David A. Leinster, R. Thompson, Tiziana Schioppa, Jeffery Nemeth, Jessica Vermeulen, Naveena Singh, Norbert Avril, Jeff Cummings, Elton Rexhepaj, Karin Jirström, William M. Gallagher, Donal J. Brennan, Iain A. McNeish, Frances R. Balkwill	2011	313
14	A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment Cancer Research ·Hagen Kulbe, Probir Chakravarty, David A. Leinster, Kellie A. Charles, Joseph Kwong, Richard G. Thompson, Jermaine Coward, Tiziana Schioppa, Stephen C. Robinson, William M. Gallagher, Laura Galletta, Michael A. Salako, John F. Smyth, Thorsten Hagemann, Donal J. Brennan, David D.L. Bowtell, Frances R. Balkwill	2011	171
15	Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy Cancer Discovery ·David G. DeNardo, Donal J. Brennan, Elton Rexhepaj, Brian Ruffell, Stephen L. Shiao, Stephen F. Madden, William M. Gallagher, Nikhil Wadhwani, Scott D. Keil, Sharfaa A. Junaid, Hope S. Rugo, E. Shelley Hwang, Karin Jirström, Brian L. West, Lisa M. Coussens Hit paper breakdown →	2011	1320
16	Receptor Tyrosine Kinase Signaling Favors a Protumorigenic State in Breast Cancer Cells by Inhibiting the Adaptive Immune Response Cancer Research ·Josie Ursini‐Siegel, Sean Cory, Dongmei Zuo, W. Rod Hardy, Elton Rexhepaj, Sonya H.L. Lam, Babette Schade, Karin Jirström, Eva Bjur, Ciriaco A. Piccirillo, David G. DeNardo, Lisa M. Coussens, Donal J. Brennan, William M. Gallagher, Morag Park, Tony Pawson, Michael Hallett, William J. Muller	2010	24
17	Altered Cytoplasmic-to-Nuclear Ratio of Survivin Is a Prognostic Indicator in Breast Cancer Clinical Cancer Research ·Donal J. Brennan, Elton Rexhepaj, Sallyann L. O’Brien, Elaine McSherry, Darran P. O’Connor, Ailís Fagan, Aedín C. Culhane, Desmond G. Higgins, Karin Jirström, Robert C. Millikan, Göran Landberg, Michael J. Duffy, Stephen M. Hewitt, William M. Gallagher	2008	71
18	CA IX is an Independent Prognostic Marker in Premenopausal Breast Cancer Patients with One to Three Positive Lymph Nodes and a Putative Marker of Radiation Resistance Clinical Cancer Research ·Donal J. Brennan, Karin Jirström, Åsa Kronblad, Robert C. Millikan, Göran Landberg, Michael J. Duffy, Lisa Rydén, William M. Gallagher, Sallyann L. O’Brien	2006	107
19	Carbonic anhydrase IX is a new independent prognostic marker in pre-menopausal breast cancer patients with 1 to 3 positive lymph nodes Cancer Research ·Donal J. Brennan, Åsa Kronblad, Karin Jirström, Göran Landberg, Michael J. Duffy, William M. Gallagher, Sallyann L. O Brien	2006	3
20	Low pH induces co-ordinate regulation of gene expression in oesophageal cells Carcinogenesis ·Shane P. Duggan, William M. Gallagher, Edward Fox, Mohamed Abdel-Latif, John V. Reynolds, Dermot Kelleher	2005	49

About William M. Gallagher

William M. Gallagher is a scholar working on Cancer Research, Oncology, Biophysics, Molecular Biology and Immunology and Allergy, having authored 257 papers that have together received 15.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (19 papers), HER2/EGFR in Cancer Research (18 papers), Cancer Genomics and Diagnostics (18 papers), Advanced Proteomics Techniques and Applications (15 papers), Gene expression and cancer classification (15 papers), Prostate Cancer Treatment and Research (14 papers), Epigenetics and DNA Methylation (14 papers) and Estrogen and related hormone effects (13 papers). The work is most often cited by research in Cancer Research (3.6k citations), Oncology (4.0k citations), Immunology (2.4k citations), Molecular Biology (6.8k citations) and Pulmonary and Respiratory Medicine (2.4k citations). William M. Gallagher has collaborated with scholars based in Ireland, United States and Sweden. Frequent co-authors include Annette T. Byrne, Aisling O’Connor, Donal J. Brennan, Donal F. O’Shea, Darran P. O’Connor, Elton Rexhepaj, J. Killoran, Karin Jirström, Lorcan T. Allen and Stephen F. Madden. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Expert Review of Molecular Diagnostics, BMC Cancer and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact